These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
828 related items for PubMed ID: 17784880
1. High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy. Pierorazio PM, Lambert SM, Matsukhani M, Sprenkle PC, McCann TR, Katz AE, Olsson CA, Benson MC, McKiernan JM. BJU Int; 2007 Nov; 100(5):1066-70. PubMed ID: 17784880 [Abstract] [Full Text] [Related]
2. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO. J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760 [Abstract] [Full Text] [Related]
3. Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigen. San Francisco IF, Regan MM, Olumi AF, DeWolf WC. J Urol; 2004 Apr; 171(4):1492-9. PubMed ID: 15017206 [Abstract] [Full Text] [Related]
5. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer? Haukaas SA, Halvorsen OJ, Daehlin L, Hostmark J, Akslen LA. BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328 [Abstract] [Full Text] [Related]
6. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. Nelson BA, Shappell SB, Chang SS, Wells N, Farnham SB, Smith JA, Cookson MS. BJU Int; 2006 Jun; 97(6):1169-72. PubMed ID: 16686706 [Abstract] [Full Text] [Related]
7. Is prostate-specific antigen (PSA) density better than the preoperative PSA level in predicting early biochemical recurrence of prostate cancer after radical prostatectomy? Jones TD, Koch MO, Bunde PJ, Cheng L. BJU Int; 2006 Mar; 97(3):480-4. PubMed ID: 16469012 [Abstract] [Full Text] [Related]
8. Visual estimation of tumour extent is not an independent predictor of prostate specific antigen recurrence. Jones TD, Koch MO, Lin H, Cheng L. BJU Int; 2005 Dec; 96(9):1253-7. PubMed ID: 16287440 [Abstract] [Full Text] [Related]
9. Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer? van Oort IM, Schout BM, Kiemeney LA, Hulsbergen CA, Witjes JA. Eur Urol; 2005 Oct; 48(4):572-6. PubMed ID: 16046051 [Abstract] [Full Text] [Related]
10. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC. Cancer; 2003 Dec 01; 98(11):2344-50. PubMed ID: 14635068 [Abstract] [Full Text] [Related]
11. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens. Marks RA, Koch MO, Lopez-Beltran A, Montironi R, Juliar BE, Cheng L. Hum Pathol; 2007 Aug 01; 38(8):1207-11. PubMed ID: 17490720 [Abstract] [Full Text] [Related]
12. Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers. Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Frank I, Blute ML. BJU Int; 2008 Feb 01; 101(3):299-304. PubMed ID: 17922854 [Abstract] [Full Text] [Related]
13. The outcome of patients with pathological Gleason score >or=8 prostate cancer after radical prostatectomy. Rodriguez-Covarrubias F, Larre S, De La Taille A, Abbou CC, Salomon L. BJU Int; 2008 Feb 01; 101(3):305-7. PubMed ID: 17941921 [Abstract] [Full Text] [Related]
14. Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan. Yokomizo A, Murai M, Baba S, Ogawa O, Tsukamoto T, Niwakawa M, Tobisu K, Kinukawa N, Naito S. BJU Int; 2006 Sep 01; 98(3):549-53. PubMed ID: 16925752 [Abstract] [Full Text] [Related]
15. Is there a difference in outcome after radical prostatectomy between patients with biopsy Gleason sums 4, 5, and 6? Results from the SEARCH database. Freedland SJ, Amling CL, Terris MK, Presti JC, Aronson WJ, Elashoff D, Kane CJ, SEARCH Database Study Group. Prostate Cancer Prostatic Dis; 2003 Sep 01; 6(3):261-5. PubMed ID: 12970733 [Abstract] [Full Text] [Related]
16. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer. D'Amico AV, Wu Y, Chen MH, Nash M, Renshaw AA, Richie JP. J Urol; 2001 Jan 01; 165(1):126-9. PubMed ID: 11125380 [Abstract] [Full Text] [Related]
17. Impact of patient age on biochemical recurrence rates following radical prostatectomy. Magheli A, Rais-Bahrami S, Humphreys EB, Peck HJ, Trock BJ, Gonzalgo ML. J Urol; 2007 Nov 01; 178(5):1933-7; discussion 1937-8. PubMed ID: 17868723 [Abstract] [Full Text] [Related]
18. Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables. Lau WK, Bergstralh EJ, Blute ML, Slezak JM, Zincke H. J Urol; 2002 Jan 01; 167(1):117-22. PubMed ID: 11743287 [Abstract] [Full Text] [Related]
19. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer. Sengupta S, Blute ML, Bagniewski SM, Inman B, Leibovich BC, Slezak JM, Myers RP, Zincke H. BJU Int; 2008 Jan 01; 101(2):170-4. PubMed ID: 18173824 [Abstract] [Full Text] [Related]
20. Prevalence of high-grade prostatic intraepithelial neoplasia in prostate gland of Korean men: comparisons between radical prostatectomy and cystoprostatectomy. Han KS, Jeong IG, Joung JY, Yang SO, Chung J, Seo HK, Park WS, Lee KH. Urology; 2007 Dec 01; 70(6):1100-3. PubMed ID: 18158026 [Abstract] [Full Text] [Related] Page: [Next] [New Search]